4821 - 4830 of 7939 Results
Title
Year
- Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study2019RESTRICTEDTitle: Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 2Start Page: 135End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30396-5Citation Count: 93
- Experience and Impact of OFF Periods in Parkinson’s Disease: A Survey of Physicians, Patients, and Carepartners2019RESTRICTEDTitle: Experience and Impact of OFF Periods in Parkinson’s Disease: A Survey of Physicians, Patients, and CarepartnersJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 1Start Page: 315End Page: 324Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-191785Citation Count: 7
-
OPENTitle: Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next StepsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 1Start Page: 19End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191854Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191854?id=journal-of-parkinsons-disease%2Fjpd191854Citation Count: 27
- LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients2019OPENTitle: LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patientsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-13413-wBest OA location URL: https://www.nature.com/articles/s41467-019-13413-w.pdfCitation Count: 145
-
RESTRICTEDTitle: Targeting Alpha-Synuclein as a Therapy for Parkinson’s DiseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2019.00299Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2019.00299/pdfCitation Count: 217
-
OPENTitle: Cerebellar Deep Brain Stimulation for Acquired HemidystoniaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 188End Page: 193Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12876Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12876Citation Count: 47
- Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's Disease2019RESTRICTEDTitle: Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 3Start Page: 457End Page: 467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27928Citation Count: 50
- Effectiveness of Physiotherapy on Freezing of Gait in Parkinson's Disease: A Systematic Review and Meta‐Analyses2019RESTRICTEDTitle: Effectiveness of Physiotherapy on Freezing of Gait in Parkinson's Disease: A Systematic Review and Meta‐AnalysesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 523End Page: 536Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27936Citation Count: 54
- Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration2019OPENTitle: Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegenerationJournal Name: The FASEB JournalPublisher: WileyVol: 34Issue #: 1Start Page: 1679End Page: 1694Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.201900567rrBest OA location URL: https://europepmc.org/articles/pmc7212500?pdf=renderCitation Count: 80
-
RESTRICTEDTitle: Suicidal risk and demoralization in Parkinson diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 267Issue #: 4Start Page: 966End Page: 974Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-019-09632-2Citation Count: 25